Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

Reviews & Analysis npj Precision Oncology

IJMS, Free Full-Text

Frontiers The Emerging Roles of Long Noncoding RNAs as Hallmarks of Lung Cancer

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma

HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications

Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment - ScienceDirect

Circulating miRNAs as prognostic biomarkers in renal cell carcinoma.

The levels of eight serum lncRNAs in patients with HCC, CHB, LC and

The serum 2-lncRNA diagnostic model. The relative expression level of a

Frontiers Targeting lncRNAs of colorectal cancers with natural products